HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR.
Bisht K, Brunck ME, Matsumoto T, McGirr C, Nowlan B, Fleming W, Keech T, Magor G, Perkins AC, Davies J, Walkinshaw G, Flippin L, Winkler IG, Levesque JP.
Bisht K, et al. Among authors: walkinshaw g.
Blood Adv. 2019 Feb 12;3(3):406-418. doi: 10.1182/bloodadvances.2018017566.
Blood Adv. 2019.
PMID: 30733301
Free PMC article.